Evome Medical Technologies Inc.
LNDZF
$0.0112
-$0.0488-81.33%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 6.97M | 7.30M | 8.46M | 10.63M | 14.17M |
| Total Revenue | 6.97M | 7.30M | 8.46M | 10.63M | 14.17M |
| Cost of Revenue | 7.08M | 7.98M | 10.07M | 11.61M | 14.52M |
| Gross Profit | -107.90K | -680.70K | -1.61M | -981.50K | -351.80K |
| SG&A Expenses | -- | -- | -- | -- | -- |
| Depreciation & Amortization | 592.30K | 596.90K | 752.90K | 920.10K | 883.20K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.67M | 8.58M | 10.82M | 12.53M | 15.40M |
| Operating Income | -700.10K | -1.28M | -2.36M | -1.90M | -1.24M |
| Income Before Tax | -842.70K | -1.66M | -3.18M | -11.62M | 2.24M |
| Income Tax Expenses | 0.00 | 8.60K | -- | 6.60K | 7.10K |
| Earnings from Continuing Operations | -842.70K | -1.67M | -3.18M | -11.62M | 2.23M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -842.70K | -1.67M | -3.18M | -11.62M | 2.23M |
| EBIT | -- | -- | -- | -- | -- |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.01 | -0.02 | -0.04 | -0.15 | 0.03 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.02 | -0.01 | 0.00 |
| EPS Diluted | -0.01 | -0.02 | -0.04 | -0.15 | 0.03 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.02 | -0.01 | 0.00 |
| Average Basic Shares Outstanding | 91.16M | 91.16M | 86.05M | 79.37M | 77.98M |
| Average Diluted Shares Outstanding | 91.16M | 91.16M | 86.05M | 79.37M | 77.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
